Sun Pharma has snapped up Ocular Technologies from Auven Therapeutics, adding to its growing eyecare medicines pipeline.

It's become well-recognized that pharma companies need to move beyond the "not invented here" mindset and tap into the scientific expertise of…

China's FDA says reports that 83% of trials have fabricated results are incorrect, but the numbers suggest the country still has a big data-integrity…

Daiichi Sankyo's ambition to build a pipeline of new oncology drugs may have just taken another big hit.

Celltrion has new data in hand from a Phase III trial of its Rituxan biosimilar CT-P10, putting it in pole position to grab a piece of the brand's $7.39…

Novartis will shutter two Asian research facilities, but says Shanghai's position as third R&D hub alongside Basel and Cambridge is secure.

If Hilleman Labs is successful in scouting for a rotavirus vaccine partnership, India might see a new force added to its efforts to fight child and infant…

Sun Pharmaceutical Industries has taken the lead in a fiercely contested race to market with Johnson & Johnson for a new class of psoriasis drug.

R&D